Expertise in
9
conditions

Dr. Amit K. Agarwal

Pediatric Pulmonology
Arkansas Children's Hospital
1 Childrens Way, 
Little Rock, AR 
Accepting New Patients
Expertise in
9
conditions
Arkansas Children's Hospital
1 Childrens Way, 
Little Rock, AR 

Overview

Amit Agarwal is a Pediatric Pulmonologist practicing medicine in Little Rock, Arkansas.

Dr. Agarwal is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Bronchopulmonary Dysplasia, Relapsed Refractory Multiple Myeloma (RRMM), Stridor, Parathyroidectomy, and Thyroidectomy.

He is actively involved in clinical research, co-authoring 702 peer reviewed articles and participating in 4 clinical trials. Dr. Agarwal is currently accepting new patients.

Specialties

Pediatric Pulmonology

Licenses

Pediatric Pulmonology in AR

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
QualChoice
  • MEDICARE MAPD
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 9 Less Insurance Carriers -

Locations

Arkansas Children's Hospital
1 Childrens Way, Little Rock, AR 72202
Other Locations
Uams Sats Program
4301 W Markham St, Little Rock, AR 72205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib, and Dexamethasone (RVD) to High-Dose Treatment With Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients Up to 65 Years of Age
A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib, and Dexamethasone (RVD) to High-Dose Treatment With Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients Up to 65 Years of Age
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Procedure
Study Drugs: Lenalidomide, Bortezomib, Dexamethasone
Study Phase: Phase 3
A Phase 1a/1b Multicenter, Single-Arm, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Preliminary Activity of Oral ACY-241 Alone and in Combination With Pomalidomide and Low-Dose Dexamethasone in Patients With Relapsed or Relapsed-and-Refractory Multiple Myeloma
A Phase 1a/1b Multicenter, Single-Arm, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Preliminary Activity of Oral ACY-241 Alone and in Combination With Pomalidomide and Low-Dose Dexamethasone in Patients With Relapsed or Relapsed-and-Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: July 09, 2024
Intervention Type: Drug
Study Drugs: ACY-241, Pomalidomide, Dexamethasone
Study Phase: Phase 1
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

702 Total Publications

Astrocyte redox imbalance underlies prelimbic neuronal hypoactivity and maladaptive affective behaviors in epilepsy.
Astrocyte redox imbalance underlies prelimbic neuronal hypoactivity and maladaptive affective behaviors in epilepsy.
Journal: Science advances
Published: July 29, 2026
Similar Doctors
Expertise in
2
conditions
Dr. Ariel Berlinski
Pediatric Pulmonology
Expertise in
2
conditions
Dr. Ariel Berlinski
Pediatric Pulmonology
Referral may be required

Uams Sats Program

4301 W Markham St, 
Little Rock, AR 
 (1.8 miles away)
501-364-1006
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ariel Berlinski is a Pediatric Pulmonologist practicing medicine in Little Rock, Arkansas. Dr. Berlinski is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis and Asthma. Dr. Berlinski is currently accepting new patients.

Expertise in
1
conditions
Dr. Jennifer S. Guimbellot
Pediatric Pulmonology
Expertise in
1
conditions
Dr. Jennifer S. Guimbellot
Pediatric Pulmonology
Referral may be required

Arkansas Children's Hospital

1 Childrens Way, 
Little Rock, AR 
 (0.1 miles away)
501-364-1006
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jennifer Guimbellot is a Pediatric Pulmonologist practicing medicine in Little Rock, Arkansas. Dr. Guimbellot is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Pseudomonas Stutzeri Infections, and Lung Transplant. Dr. Guimbellot is currently accepting new patients.

Expertise in
0
conditions
Dr. Erhan Ararat
Pediatric Pulmonology
Expertise in
0
conditions
Dr. Erhan Ararat
Pediatric Pulmonology
Referral may be required

Arkansas Children's Hospital

1 Childrens Way, 
Little Rock, AR 
 (0.1 miles away)
501-364-1100
Languages Spoken:
English, Turkish
See accepted insurances
Accepting New Patients

Erhan Ararat is a Pediatric Pulmonologist practicing medicine in Little Rock, Arkansas. His clinical expertise encompasses Asthma, Cystic Fibrosis, and Duchenne Muscular Dystrophy. Dr. Ararat is currently accepting new patients.

Frequently Asked Questions about Dr. Amit K. Agarwal

How do I make an appointment with Dr. Amit K. Agarwal?

You can book an appointment with Dr. Amit K. Agarwal by calling their office at 501-364-1100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Amit K. Agarwal a top-rated expert for Bronchopulmonary Dysplasia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amit K. Agarwal is classified as an Elite expert for Bronchopulmonary Dysplasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Amit K. Agarwal specialize in?

While Dr. Amit K. Agarwal is a Pediatric Pulmonology, they have specific expertise in Bronchopulmonary Dysplasia, Parathyroidectomy, and Thyroidectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Pulmonology.

Does Dr. Amit K. Agarwal participate in research or clinical trials?

Yes. Dr. Amit K. Agarwal has published 702 articles and abstracts on conditions like Bronchopulmonary Dysplasia. You can view a list of Dr. Amit K. Agarwal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Amit K. Agarwal accept my insurance?

Dr. Amit K. Agarwal accepts most major insurance plans, including Anthem BCBS and Arkansas Health and Wellness. We recommend calling the office directly at 501-364-1100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Agarwal's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 20 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile